Dicot Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	56.2	69.19	113.42	47.34	9.38	30.33
Cash & Short-Term Investments	56.2	69.19	113.42	47.34	9.38	30.33
Cash Growth	-39.44%	-39.00%	139.58%	404.88%	-69.08%	49.20%
Other Receivables	5.4	2.38	3.47	2.3	1.14	1.01
Receivables	5.4	2.38	3.47	2.3	1.14	1.01
Inventory	9.3	8	5.38	3.4	1.49	-
Prepaid Expenses	-	5.89	1.35	0.5	0.34	0.4
Other Current Assets	-	-	-	-0	-	-
Total Current Assets	70.9	85.46	123.62	53.54	12.35	31.74
Property, Plant & Equipment	-	-	-	0.01	0.02	0.03
Total Assets	70.9	85.46	123.62	53.56	12.37	31.77
Accounts Payable	-	6.12	6.84	4.54	3.42	2.58
Accrued Expenses	-	4.87	4.05	3.98	1.19	0.66
Other Current Liabilities	12.4	1.12	1.07	0.64	2.41	0.19
Total Current Liabilities	12.4	12.11	11.96	9.16	7.01	3.42
Total Liabilities	12.4	12.11	11.96	9.16	7.01	3.42
Common Stock	14.1	14.07	12.45	5.72	17.14	12.86
Additional Paid-In Capital	339.1	339.31	299	180.76	86.15	81.67
Retained Earnings	-	-280.02	-199.79	-142.09	-97.93	-66.18
Comprehensive Income & Other	-294.7	-	-	-	-	-
Shareholders' Equity	58.5	73.36	111.67	44.39	5.36	28.35
Total Liabilities & Equity	70.9	85.46	123.62	53.56	12.37	31.77
Net Cash (Debt)	56.2	69.19	113.42	47.34	9.38	30.33
Net Cash Growth	-39.44%	-39.00%	139.58%	404.88%	-69.08%	49.20%
Net Cash Per Share	0.03	0.04	0.10	0.09	0.08	0.47
Filing Date Shares Outstanding	2,009	2,009	1,779	817.56	137.1	102.9
Total Common Shares Outstanding	2,009	2,009	1,779	817.56	137.1	102.9
Working Capital	58.5	73.36	111.67	44.38	5.34	28.32
Book Value Per Share	0.03	0.04	0.06	0.05	0.04	0.28
Tangible Book Value	58.5	73.36	111.67	44.39	5.36	28.35
Tangible Book Value Per Share	0.03	0.04	0.06	0.05	0.04	0.28
Machinery	-	-	-	0.04	0.04	0.04